162 related articles for article (PubMed ID: 38513098)
1. IL7 increases targeted lipid nanoparticle-mediated mRNA expression in T cells in vitro and in vivo by enhancing T cell protein translation.
Tilsed CM; Sadiq BA; Papp TE; Areesawangkit P; Kimura K; Noguera-Ortega E; Scholler J; Cerda N; Aghajanian H; Bot A; Mui B; Tam Y; Weissman D; June CH; Albelda SM; Parhiz H
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2319856121. PubMed ID: 38513098
[TBL] [Abstract][Full Text] [Related]
2. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift.
Kheirolomoom A; Kare AJ; Ingham ES; Paulmurugan R; Robinson ER; Baikoghli M; Inayathullah M; Seo JW; Wang J; Fite BZ; Wu B; Tumbale SK; Raie MN; Cheng RH; Nichols L; Borowsky AD; Ferrara KW
Biomaterials; 2022 Feb; 281():121339. PubMed ID: 35078042
[TBL] [Abstract][Full Text] [Related]
3. Optimized RNA interference therapeutics combined with interleukin-2 mRNA for treating hepatitis B virus infection.
Zai W; Yang M; Jiang K; Guan J; Wang H; Hu K; Huang C; Chen J; Fu W; Zhan C; Yuan Z
Signal Transduct Target Ther; 2024 Jun; 9(1):150. PubMed ID: 38902241
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 7 enhances the proliferation and effector function of tumor-infiltrating lymphocytes from renal-cell carcinoma.
Sica D; Rayman P; Stanley J; Edinger M; Tubbs RR; Klein E; Bukowski R; Finke JH
Int J Cancer; 1993 Apr; 53(6):941-7. PubMed ID: 8473051
[TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of the effects of interleukins 2, 4 and 7 on enhancing the immunotherapeutic efficacy of anti-tumor cytotoxic T lymphocytes.
Lynch DH; Namen AE; Miller RE
Eur J Immunol; 1991 Dec; 21(12):2977-85. PubMed ID: 1684156
[TBL] [Abstract][Full Text] [Related]
6. Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs.
Tombácz I; Laczkó D; Shahnawaz H; Muramatsu H; Natesan A; Yadegari A; Papp TE; Alameh MG; Shuvaev V; Mui BL; Tam YK; Muzykantov V; Pardi N; Weissman D; Parhiz H
Mol Ther; 2021 Nov; 29(11):3293-3304. PubMed ID: 34091054
[TBL] [Abstract][Full Text] [Related]
7. Development of a long-term, IL7 dependent cell death rescue assay in CD4+ T-cells.
Perez-Witzke D; Parmar R; Blancq I; Turpin MA; Ponchel F
J Immunol Methods; 2021 Jun; 493():113020. PubMed ID: 33705736
[TBL] [Abstract][Full Text] [Related]
8. R848 Adjuvant Laden With Self-Assembled Nanoparticle-Based mRNA Vaccine Elicits Protective Immunity Against H5N1 in Mice.
Zhuang X; Chen L; Yang S; Xia S; Xu Z; Zhang T; Zeng B; Yu T; Yu N; Wang W; Lu H; Tian M; Jin N
Front Immunol; 2022; 13():836274. PubMed ID: 35711431
[TBL] [Abstract][Full Text] [Related]
9. Intravaginal Administration of Fc-Fused IL7 Suppresses the Cervicovaginal Tumor by Recruiting HPV DNA Vaccine-Induced CD8 T Cells.
Choi YW; Kang MC; Seo YB; Namkoong H; Park Y; Choi DH; Suh YS; Lee SW; Sung YC; Jin HT
Clin Cancer Res; 2016 Dec; 22(23):5898-5908. PubMed ID: 27407095
[TBL] [Abstract][Full Text] [Related]
10. IL7-Fc Enhances the Efficacy of Adoptive T Cell Therapy under Lymphopenic Conditions in a Murine Melanoma Model.
Yu EM; Cho E; Singh R; Kim SH; Han C; Han S; Lee DG; Kim YH; Kwon BS; Choi BK
Cells; 2021 Aug; 10(8):. PubMed ID: 34440787
[TBL] [Abstract][Full Text] [Related]
11. Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.
Tam A; Kulkarni J; An K; Li L; Dorscheid DR; Singhera GK; Bernatchez P; Reid G; Chan K; Witzigmann D; Cullis PR; Sin DD; Lim CJ
Eur J Pharm Sci; 2022 Sep; 176():106234. PubMed ID: 35688311
[TBL] [Abstract][Full Text] [Related]
12. Lipid nanoparticle-mediated lymph node-targeting delivery of mRNA cancer vaccine elicits robust CD8
Chen J; Ye Z; Huang C; Qiu M; Song D; Li Y; Xu Q
Proc Natl Acad Sci U S A; 2022 Aug; 119(34):e2207841119. PubMed ID: 35969778
[TBL] [Abstract][Full Text] [Related]
13. Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV
Valentin A; Bergamaschi C; Rosati M; Angel M; Burns R; Agarwal M; Gergen J; Petsch B; Oostvogels L; Loeliger E; Chew KW; Deeks SG; Mullins JI; Pavlakis GN; Felber BK
Front Immunol; 2022; 13():945706. PubMed ID: 35935984
[TBL] [Abstract][Full Text] [Related]
14. Redirection of CD4+ and CD8+ T lymphocytes via an anti-CD3 × anti-CD19 bi-specific antibody combined with cytosine arabinoside and the efficient lysis of patient-derived B-ALL cells.
Fan D; Li W; Yang Y; Zhang X; Zhang Q; Yan Y; Yang M; Wang J; Xiong D
J Hematol Oncol; 2015 Oct; 8():108. PubMed ID: 26444983
[TBL] [Abstract][Full Text] [Related]
15. Lipid-nanoparticle-encapsulated mRNA vaccines induce protective memory CD8 T cells against a lethal viral infection.
Knudson CJ; Alves-Peixoto P; Muramatsu H; Stotesbury C; Tang L; Lin PJC; Tam YK; Weissman D; Pardi N; Sigal LJ
Mol Ther; 2021 Sep; 29(9):2769-2781. PubMed ID: 33992803
[TBL] [Abstract][Full Text] [Related]
16. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB
Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019
[TBL] [Abstract][Full Text] [Related]
17. Systemic Gene Silencing in Primary T Lymphocytes Using Targeted Lipid Nanoparticles.
Ramishetti S; Kedmi R; Goldsmith M; Leonard F; Sprague AG; Godin B; Gozin M; Cullis PR; Dykxhoorn DM; Peer D
ACS Nano; 2015 Jul; 9(7):6706-16. PubMed ID: 26042619
[TBL] [Abstract][Full Text] [Related]
18. Targeted lipid nanoparticle delivery of calcitriol to human monocyte-derived macrophages in vitro and in vivo: investigation of the anti-inflammatory effects of calcitriol.
Rafique A; Etzerodt A; Graversen JH; Moestrup SK; Dagnæs-Hansen F; Møller HJ
Int J Nanomedicine; 2019; 14():2829-2846. PubMed ID: 31114197
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.
van Roon JA; Glaudemans KA; Bijlsma JW; Lafeber FP
Ann Rheum Dis; 2003 Feb; 62(2):113-9. PubMed ID: 12525379
[TBL] [Abstract][Full Text] [Related]
20. Engineered mRNA-expressed bispecific antibody prevent intestinal cancer via lipid nanoparticle delivery.
Wu L; Wang W; Tian J; Qi C; Cai Z; Yan W; Xuan S; Shang A
Bioengineered; 2021 Dec; 12(2):12383-12393. PubMed ID: 34895063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
